Reviewing Agency Inaction after Heckler v. Chaney
نویسندگان
چکیده
منابع مشابه
Action v inaction: a case history in ethics.
The motives behind the author's decision to resuscitate a patient are examined. This is prompted by the realisation that he ignored the man's apparent wish not to be saved for fear of criticism from both relatives and colleagues. The way in which decisions are made when the interests of the doctor and the patient clash are briefly explored. Self interest may play a more significant role than is...
متن کاملKukier & Chaney: Remediation of Nickel Phytotoxicity
Brassica oleracea L. var. capitata L.) and beetroot (Beta vulgaris L.) was obtained at 2075 and 4505 mg kg 1 Ni In situ remediation (phytostabilization) is a cost-effective solution in soil, respectively. On the muck soil containing 1200 for restoring the productivity of metal-contaminated soils and protection of food chains. A pot experiment with wheat (Triticum aestivum mg kg 1 Ni, the predic...
متن کاملWHO downgrades Tamiflu after reviewing evidence
Editorial WHO downgraded oseltamivir (Tamiflu) New Products Hypnotic (sleeping pill), suvorexant (brand name Belsomra) A substance that causes narcolepsy and cataplexy Teriparatide More harm than benefit: Review Insomnia, Optimal Sleep Duration and Harm of Sleeping pills Pneumonia caused by proton pump inhibitors (PPI) (1) meta-analysis (2) Critical appraisal of a study CONTENTS (December 2017,...
متن کاملFrom Power to Inaction.
Research has shown that people who feel powerful are more likely to act than those who feel powerless, whereas people who feel ambivalent are less likely to act than those whose reactions are univalent (entirely positive or entirely negative). But what happens when powerful people also are ambivalent? On the basis of the self-validation theory of judgment, we hypothesized that power and ambival...
متن کاملReviewing the evidence supporting predictive biomarkers in European medicines agency indications and contraindications using visual plots
Objectives Predictive biomarkers can be used to identify most suitable treatments for patients. To maximise patient benefit valid predictive biomarkers need to be used and several trial designs have been proposed to achieve this. We aimed to review the evidence considered sufficient by the European Medicines Agency (EMA) for inclusion of a predictive biomarker in a drug indication or contraindi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The University of Chicago Law Review
سال: 1985
ISSN: 0041-9494
DOI: 10.2307/1599631